【结 构 式】 |
【分子编号】47686 【品名】(+)-2-(7-chloro[1,8]naphthyridin-2-yl)-3-[[(1R,2R,6S,8R)-4-isopentyl-2,9,9-trimethyl-3,5-dioxatricyclo[6.1.1.0(2,6)]dec-4-yl]methyl]-1-isoindolinone 【CA登记号】 |
【 分 子 式 】C33H38ClN3O3 【 分 子 量 】560.13584 【元素组成】C 70.76% H 6.84% Cl 6.33% N 7.5% O 8.57% |
与该中间体有关的原料药合成路线共 1 条
合成路线1
该中间体在本合成路线中的序号:(XVI)The optical resolution of racemic pagoclone (VII) can also be performed by reaction with (-)-(1R,2R,3S,5R)-pinanediol (XIV) by means of PPTS in refluxing dichloroethane to give the ketal (XV) as a diastereomeric mixture separated by crystallization. Finally, hydrolysis of the desired diastereomer (XVI) with 12N HCl affords the (+)-enantiomer, pagoclone.
【1】 Silvestre, J.S.; Castaner, J.; Leeson, P.A.; Sorbera, L.A.; Pagoclone. Drugs Fut 2001, 26, 7, 651. |
【2】 Barreau, M.; Cotrel, C.; Dubroeucq, M.-C.; Manfre, F. (Aventis Pharma SA); Method for preparing enantiomers of an isoindolinone deriv.. WO 9313098 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(VII) | 47678 | 2-(7-chloro[1,8]naphthyridin-2-yl)-3-(5-methyl-2-oxohexyl)-1-isoindolinone | C23H22ClN3O2 | 详情 | 详情 | |
(XIV) | 16644 | (-)-Pinanediol; (1R,2R,3S,5R)-2,6,6-trimethylbicyclo[3.1.1]heptane-2,3-diol | 20536-52-1 | C10H18O2 | 详情 | 详情 |
(XV) | 47685 | (rac)-2-(7-chloro[1,8]naphthyridin-2-yl)-3-[[(1R,2R,6S,8R)-4-isopentyl-2,9,9-trimethyl-3,5-dioxatricyclo[6.1.1.0(2,6)]dec-4-yl]methyl]-1-isoindolinone | C33H38ClN3O3 | 详情 | 详情 | |
(XVI) | 47686 | (+)-2-(7-chloro[1,8]naphthyridin-2-yl)-3-[[(1R,2R,6S,8R)-4-isopentyl-2,9,9-trimethyl-3,5-dioxatricyclo[6.1.1.0(2,6)]dec-4-yl]methyl]-1-isoindolinone | C33H38ClN3O3 | 详情 | 详情 |
Extended Information